BRCA1 and ovarian carcinoma: Notably, carriers of pathogenic BRCA1 or BRCA2 variants (path_BRCA1 or path_BRCA2) have an increased risk of developing BC (average lifetime risk of 35–85%) and ovarian cancer (average lifetime risk 11–39%).